ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 153 filers reported holding ITEOS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $347,835 | +267.2% | 23,439 | +237.5% | 0.00% | – |
Q1 2024 | $94,716 | -89.9% | 6,944 | -91.9% | 0.00% | -100.0% |
Q4 2023 | $938,722 | +868.5% | 85,728 | +1071.0% | 0.00% | – |
Q2 2023 | $96,930 | -47.9% | 7,321 | -46.5% | 0.00% | -100.0% |
Q1 2023 | $186,171 | +64.8% | 13,679 | +148.7% | 0.00% | – |
Q2 2022 | $113,000 | – | 5,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,738,785 | $40,643,569 | 22.32% |
MPM BioImpact LLC | 1,745,943 | $25,909,794 | 4.03% |
Boxer Capital, LLC | 2,946,915 | $43,732,219 | 2.30% |
Saturn V Capital Management LP | 367,429 | $5,452,646 | 2.06% |
Vestal Point Capital, LP | 1,750,000 | $25,970,000 | 1.94% |
EcoR1 Capital, LLC | 3,249,835 | $48,227,551 | 1.48% |
683 Capital Management, LLC | 1,115,000 | $16,546,599 | 1.25% |
K2 PRINCIPAL FUND, L.P. | 450,000 | $6,678,000 | 1.24% |
K2 PRINCIPAL FUND, L.P. | 257,080 | $3,815,067 | 0.71% |
RA Capital Management | 3,517,259 | $52,196,124 | 0.69% |